We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Sector Composition

Rank Sector Weight
1 Technology 13.98%
2 Financials 13.14%
3 Industrials 10.38%
4 Healthcare 8.96%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
301
T. Rowe Price
TROW
$24.3B
$1.66M 0.08%
15,425
-515
-3% -$57.4K
ATR icon
302
AptarGroup
ATR
$8.57B
$1.66M 0.08%
18,485
-197
-1% -$17.4K
MMS icon
303
Maximus
MMS
$2.84B
$1.66M 0.08%
24,864
SVC
304
Service Properties Trust
SVC
$1.05B
$1.66M 0.08%
13,091
-700
-5% -$94.2K
CRM icon
305
Salesforce
CRM
$162B
$1.65M 0.08%
14,190
-664
-4% -$76.3K
PRI icon
306
Primerica
PRI
$9.63B
$1.65M 0.08%
17,061
WGL
307
DELISTED
Wgl Holdings
WGL
$1.65M 0.08%
19,688
ALB icon
308
Albemarle
ALB
$15.3B
$1.64M 0.08%
17,717
-1,047
-6% -$115K
OHI icon
309
Omega Healthcare
OHI
$13.8B
$1.62M 0.08%
60,015
GPN icon
310
Global Payments
GPN
$22.7B
$1.61M 0.08%
14,456
-2,912
-17% -$322K
NATI
311
DELISTED
National Instruments Corp
NATI
$1.61M 0.08%
31,801
SF
312
Stifel
SF
$12.7B
$1.6M 0.08%
60,937
+2,023
+3% +$57.3K
ULTA icon
313
Ulta Beauty
ULTA
$23.3B
$1.6M 0.08%
7,828
-1,215
-13% -$263K
TTWO icon
314
Take-Two Interactive
TTWO
$46.8B
$1.6M 0.08%
16,324
-19,821
-55% -$2.22M
VRTX icon
315
Vertex Pharmaceuticals
VRTX
$134B
$1.6M 0.08%
9,790
-296
-3% -$48.3K
LAMR icon
316
Lamar Advertising Co
LAMR
$15.6B
$1.59M 0.08%
24,985
CL icon
317
Colgate-Palmolive
CL
$73.6B
$1.58M 0.08%
22,090
-498
-2% -$35.8K
MASI
318
DELISTED
Masimo
MASI
$1.58M 0.08%
17,954
-180
-1% -$15.7K
ACC
319
DELISTED
American Campus Communities, Inc.
ACC
$1.58M 0.08%
40,880
SKX
320
DELISTED
Skechers
SKX
$1.57M 0.08%
40,456
+420
+1% +$16.7K
XBI icon
321
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$1.57M 0.08%
17,945
-4,700
-21% -$429K
ITW icon
322
Illinois Tool Works
ITW
$83.5B
$1.57M 0.08%
10,014
+367
+4% +$60.9K
MD icon
323
Pediatrix Medical
MD
$2.12B
$1.56M 0.07%
28,037
BC icon
324
Brunswick
BC
$5.28B
$1.56M 0.07%
26,249
-13,600
-34% -$804K
ESRX
325
DELISTED
Express Scripts Holding Company
ESRX
$1.53M 0.07%
22,173
-659
-3% -$50.3K

Similar funds

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.